Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Find a Funding Opportunity.
NB: Council approval does not guarantee that a concept will become an initiative.
Table of Contents
- Development of Radiation/Nuclear Medical Countermeasures or Biodosimetry Biomarkers/Devices
- Adjuvant Development Program
- Asthma and Allergic Diseases Cooperative Research Centers
- Clinical Trials in Organ Transplantation in Children: Limited Competition
- Small Grants on Primary Immunodeficiency Diseases (R03)/Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)
Development of Radiation/Nuclear Medical Countermeasures or Biodosimetry Biomarkers/Devices
For the published broad agency announcement, see the March 3, 2017 solicitation, NIAID Omnibus Broad Agency Announcement.
Adjuvant Development Program
For the published broad agency announcement, see the March 3, 2017 solicitation, NIAID Omnibus Broad Agency Announcement.
Asthma and Allergic Diseases Cooperative Research Centers
For the published request for applications, see the August 10, 2016 Guide announcement, Asthma and Allergic Diseases Cooperative Research Centers (U19).
Clinical Trials in Organ Transplantation in Children: Limited Competition
For the published request for applications, see the November 28, 2016 Guide announcement, Limited Competition: Clinical Trials in Organ Transplantation in Children (CTOT-C): Mechanistic Ancillary Studies (U01).
Small Grants on Primary Immunodeficiency Diseases (R03)/Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)
For the published program announcements, see the July 21, 2017 Guide announcements, Small Grants on Primary Immunodeficiency Diseases (R03) and Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21).